However, tumors with OX40L+macrophages showed a more favorable prognosis in the late tumor stage (T3) than those with OX40L-negative macrophages; in the T1–T2 stage, there was no significant difference in PFS and DSS (Supplementary Figure S4). The gene discussed is TNFSF4; the disease is neoplasm.